J Korean Soc Pediatr Endocrinol.  2011 Apr;16(1):31-37. 10.6065/jkspe.2011.16.1.31.

Evaluation of Growth Status Using Serum IGF-I and IGFBP-3 in Children with Subclinical Hypothyroidism

Affiliations
  • 1Department of Pediatrics, Konkuk University School of Medicine, Seoul, Korea. scchung@kuh.ac.kr

Abstract

PURPOSE
The aim of this study was to evaluate growth status using the insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations in children with subclinical hypothyroidism (SCH).
METHODS
The study included 93 SCH patients (33 males and 60 females, age 8.1+/-1.9 years) and 94 healthy control subjects (31 males and 63 females, age 8.0+/-0.7 years). Patients' height and weight were measured, and their body mass index (BMI) and Z-scores were calculated. The relationship between growth parameters, including IGF-I and IGFBP-3 concentrations and thyroid functions (thyroid-stimulating hormone (TSH) and free thyroxine 4 (fT4) was explored.
RESULTS
Although weight and BMI were greater in SCH patients, the Z-score of height, weight and BMI, and serum IGF-I and IGFBP-3 levels in SCH children were not significantly different compared to the control. In SCH patients, TSH showed a negative correlation with weight Z-scores (r=-0.23, P=0.028) and BMI Z-scores (r=-0.21, P=0.048). FT4 showed a positive correlation with IGFBP-3.
CONCLUSION
The positive correlation of fT4 and IGFBP-3 and the negative relationship between TSH and weight and BMI Z-scores in SCH children suggest that subnormal thyroid functions could be related to growth impairment.

Keyword

Hypothyroidism; Growth; Child

MeSH Terms

Body Mass Index
Child
Female
Humans
Hypothyroidism
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor I
Male
Thyroid Gland
Thyroxine
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor I
Thyroxine
Full Text Links
  • JKSPE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr